# Multicenter Uveitis Steroid Treatment (MUST) Trial

> **NCT00132691** · PHASE4 · COMPLETED · sponsor: **JHSPH Center for Clinical Trials** · enrollment: 255 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** fluocinolone acetonide intraocular implant
- **DRUG:** oral corticosteroid with immunosuppressive agents as needed

## Key facts

- **NCT ID:** NCT00132691
- **Lead sponsor:** JHSPH Center for Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2016-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132691, "Multicenter Uveitis Steroid Treatment (MUST) Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00132691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*